Top 5 Safest Stocks To Watch For 2018

A squirrel eats a bread ring on a sunny day on March 30, 2017 in the center of the Ukrainian capital Kiev. / AFP PHOTO / Sergei SUPINSKY (Photo credit should read SERGEI SUPINSKY/AFP/Getty Images)

The investment landscape is littered with stocks that pay dividends, as the equity markets provide an attractive opportunity for investors to receive predictable income while retaining the possibility of share price appreciation.

A dividend is an important barometer for investors, as it provides certainty about a company’s financial well-being. As Josh Peters wrote in “The Ultimate Dividend Playbook”:

A company’s pattern of dividend payments – it’s dividend record – can offer valuable clues to underlying corporate performance, clues just as valuable as those provided by earnings reports and other financial data, and definitely more useful than the conclusions someone might draw from looking at a three-month stock chart.

Top 5 Safest Stocks To Watch For 2018: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

  • [By ]

    And while the big drug companies will experience a significant adjustment, biotech companies, with their focus on long term results and outright cures in some cases, are probably poised to perform. The best way to get invested would be with the Biotech Spider ETF (NYSE: XBI).

  • [By WWW.KIPLINGER.COM]

    Theres been follow-up, too: Valeant Pharmaceuticals Intl Inc (VRX) had to face the Senate in April for aggressively hiking prices on its drugs. Now Mylan NV (MYL) is answering to the government soon after a story showed that EpiPen prices have rocketed 400% since 2008 with no significant improvements to the treatment. This scandal, too, is rocking biotechs including (Link]recommendation SPDR S&P Biotech ETF (XBI).

Top 5 Safest Stocks To Watch For 2018: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggestedgoing long on small cap orphan biopharmaceutical stock Xenon Pharmaceuticals (NASDAQ: XENE):

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 51 percent to $4.80 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

  • [By Lisa Levin]

    Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares dropped 53 percent to $4.68 after the company disclosed that XEN801 did not meet efficacy endpoints in Phase 2 trial.

Top 5 Safest Stocks To Watch For 2018: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By Cameron Saucier]

    Evoke (Nasdaq: EVOK) is a pharmaceutical company that develops drug candidates intended to treat gastrointestinal diseases. EVOK rose 73% last month after it announced positive guidance from the FDA for Gimoti, a patented nasal delivery drug that is intended to treat gastroparesis in adult women. The positive results were from a second pre-NDA (New Drug Application) meeting Evoke had with the FDA. EVOK is currently trading at $2.67 per share and is down 9.83% as of Jan. 9 YOY.

Top 5 Safest Stocks To Watch For 2018: HCP, Inc.(HCP)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare REIT HCP, Inc. (NYSE:HCP) had an eventful 2016. The year started off quite turbulent, with dismal results from the company’s HCR ManorCare properties leading to a surprise loss, but recovered nicely as the company decided to spin off those and other troubled assets. What could be in store for HCP investors in the coming decade?

  • [By WWW.KIPLINGER.COM]

    HCP, Inc. (HCP) is a REIT that focuses on senior housing facilities and other healthcare properties.

    With a yield of 5.8%, HCP is the highest yielder of all the aristocrat dividend stocks. HCP has upped its payout for 30 straight years and now pays 57.5 cents per unit quarterly.

  • [By Matthew Frankel]

    One smart way to capitalize on this trend over the next few decades is with a healthcare REIT like HCP (NYSE:HCP), which specializes in private-pay senior housing, medical office, and life science properties.

Top 5 Safest Stocks To Watch For 2018: Colliers International Group Inc. (CIGI)

Advisors’ Opinion:

  • [By Lee Jackson]

    A10% owner of Colliers International Group Inc. (NASDAQ: CIGI) wasadding to holdings last week. Spruce House Partners bought a total of 133,800 shares of the company at $42.05 per share. The total for the buy was listed at $6 million.

Leave a Reply

Your email address will not be published. Required fields are marked *